- Home
- TAK vs ETR Comparison
TAK vs ETR Comparison
Compare TAK & ETR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TAK | ETR |
|---|---|---|
| Founded | 1781 | 1949 |
| Country | Japan | United States |
| Employees | 47455 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.4B | 52.4B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | TAK | ETR |
|---|---|---|
| Price | $15.43 | $109.39 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 18 |
| Target Price | N/A | ★ $115.25 |
| AVG Volume (30 Days) | 3.4M | ★ 3.6M |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.24% | 2.23% |
| EPS Growth | N/A | ★ 59.59 |
| EPS | N/A | ★ 0.83 |
| Revenue | N/A | ★ $12,946,686,000.00 |
| Revenue This Year | $0.16 | $8.40 |
| Revenue Next Year | $1.22 | $8.09 |
| P/E Ratio | ★ $41.25 | $130.92 |
| Revenue Growth | N/A | ★ 8.98 |
| 52 Week Low | $12.99 | $80.11 |
| 52 Week High | $18.90 | $118.45 |
Technical Indicators
Market Signals| Indicator | TAK | ETR |
|---|---|---|
| Relative Strength Index (RSI) | 33.13 | 45.91 |
| Support Level | $14.83 | $108.95 |
| Resistance Level | $15.69 | $113.23 |
| Average True Range (ATR) | 0.21 | 2.09 |
| MACD | -0.09 | -0.36 |
| Stochastic Oscillator | 29.02 | 54.55 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
About ETR Entergy Corporation
Entergy is a holding company with five regulated vertically integrated utilities that generate and distribute electricity to 3 million customers in Arkansas, Louisiana, Mississippi, and Texas. It is one of the largest power producers in the country with 27 gigawatts of rate-regulated owned and leased power generation capacity. Entergy was the second-largest nuclear owner in the US before it began retiring and selling its plants in the Northeast in 2014. It sold its two small gas utilities in Louisiana in 2025.